In almost all households visited in both regions, a history of injection use could be recorded. In Busoga 359 and in Ankole 358 of the 360 households visited in each region had ever received an injection. Injection prevalence during the past two weeks was recorded twice. During the first visit the households’ respondents were asked who in the household had last received an injection and when. If this was within the past two weeks the data was used to analyze the prevalence rate. The second follow-up visit was planned two weeks after the first. Respondents were asked if any member of the household had received an injection in this confined two week recall period. The figures for the initial visit - last time when an injection was given - indicate that 154 (42.8%) of 360 households in Busoga and 113 (31.4%) of 360 households in Ankole received an injection during the ‘last’ two weeks. In the confined two weeks recall period, one or more people in 93 (25.3%) households in Busoga and 108 (30%) households in Ankole received an injection (see Table 3), The figures show that the rates of injection use prevalence for both recordings differ; especially in Busoga, the two week recall period indicates lower rates, and presumably provides more valid rates.

Table 3: Percentage of households in which one or more injections were given in the past two weeks in Busoga and Ankole Regions

Overall the results reveal a high rate of injection use prevalence and also show that the use of injections is highest in the semi-rural and urban areas and lowest in the remote areas (see Table 4).

Table 4: Percentage of households in which one or more infections were given in the last two weeks in urban, semi-rural and remote settings in Busoga and Ankole Regions